These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15331374)

  • 1. Intracoronary administration of FGF-2: a computational model of myocardial deposition and retention.
    Filion RJ; Popel AS
    Am J Physiol Heart Circ Physiol; 2005 Jan; 288(1):H263-79. PubMed ID: 15331374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacodynamics of basic fibroblast growth factor: route of administration determines myocardial and systemic distribution.
    Lazarous DF; Shou M; Stiber JA; Dadhania DM; Thirumurti V; Hodge E; Unger EF
    Cardiovasc Res; 1997 Oct; 36(1):78-85. PubMed ID: 9415275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrapericardial administration of basic fibroblast growth factor: myocardial and tissue distribution and comparison with intracoronary and intravenous administration.
    Laham RJ; Rezaee M; Post M; Xu X; Sellke FW
    Catheter Cardiovasc Interv; 2003 Mar; 58(3):375-81. PubMed ID: 12594706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of high-pressure retrograde coronary venous delivery of FGF-2 protein.
    Fearon WF; Ikeno F; Bailey LR; Hiatt BL; Herity NA; Carter AJ; Fitzgerald PJ; Rezaee M; Yeung AC; Yock PG
    Catheter Cardiovasc Interv; 2004 Mar; 61(3):422-8. PubMed ID: 14988909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal changes in myocardial basic fibroblast growth factor (FGF-2) activity following coronary artery ligation in the dog.
    Cohen MV; Vernon J; Yaghdjian V; Hatcher VB
    J Mol Cell Cardiol; 1994 May; 26(5):683-90. PubMed ID: 8072023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracoronary and intravenous administration of basic fibroblast growth factor: myocardial and tissue distribution.
    Laham RJ; Rezaee M; Post M; Sellke FW; Braeckman RA; Hung D; Simons M
    Drug Metab Dispos; 1999 Jul; 27(7):821-6. PubMed ID: 10383927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro changes in plasma membrane heparan sulfate proteoglycans and in perlecan expression participate in the regulation of fibroblast growth factor 2 mitogenic activity.
    Guillonneau X; Tassin J; Berrou E; Bryckaert M; Courtois Y; Mascarelli F
    J Cell Physiol; 1996 Jan; 166(1):170-87. PubMed ID: 8557766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell surface heparan sulfate proteoglycans control the response of renal interstitial fibroblasts to fibroblast growth factor-2.
    Clayton A; Thomas J; Thomas GJ; Davies M; Steadman R
    Kidney Int; 2001 Jun; 59(6):2084-94. PubMed ID: 11380810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracoronary basic fibroblast growth factor enhances myocardial collateral perfusion in dogs.
    Rajanayagam MA; Shou M; Thirumurti V; Lazarous DF; Quyyumi AA; Goncalves L; Stiber J; Epstein SE; Unger EF
    J Am Coll Cardiol; 2000 Feb; 35(2):519-26. PubMed ID: 10676703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A reaction-diffusion model of basic fibroblast growth factor interactions with cell surface receptors.
    Filion RJ; Popel AS
    Ann Biomed Eng; 2004 May; 32(5):645-63. PubMed ID: 15171620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of basic fibroblast growth factor on angiogenesis in the infarcted porcine heart.
    Watanabe E; Smith DM; Sun J; Smart FW; Delcarpio JB; Roberts TB; Van Meter CH; Claycomb WC
    Basic Res Cardiol; 1998 Feb; 93(1):30-7. PubMed ID: 9538935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The kinetics of FGF-2 binding to heparan sulfate proteoglycans and MAP kinase signaling.
    Forsten-Williams K; Chua CC; Nugent MA
    J Theor Biol; 2005 Apr; 233(4):483-99. PubMed ID: 15748910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential binding of fibroblast growth factor-2 and -7 to basement membrane heparan sulfate: comparison of normal and abnormal human tissues.
    Friedl A; Chang Z; Tierney A; Rapraeger AC
    Am J Pathol; 1997 Apr; 150(4):1443-55. PubMed ID: 9094999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histidine-rich glycoprotein and platelet factor 4 mask heparan sulfate proteoglycans recognized by acidic and basic fibroblast growth factor.
    Brown KJ; Parish CR
    Biochemistry; 1994 Nov; 33(46):13918-27. PubMed ID: 7524669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acidic and basic fibroblast growth factor bind with differing affinity to the same heparan sulfate proteoglycan on BALB/c 3T3 cells: implications for potentiation of growth factor action by heparin.
    Brown KJ; Hendry IA; Parish CR
    J Cell Biochem; 1995 May; 58(1):6-14. PubMed ID: 7543903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transendocardial and transepicardial intramyocardial fibroblast growth factor-2 administration: myocardial and tissue distribution.
    Laham RJ; Post M; Rezaee M; Donnell-Fink L; Wykrzykowska JJ; Lee SU; Baim DS; Sellke FW
    Drug Metab Dispos; 2005 Aug; 33(8):1101-7. PubMed ID: 15879496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antifibrotic response of cardiac fibroblasts in hypertensive hearts through enhanced TIMP-1 expression by basic fibroblast growth factor.
    Kinoshita T; Ishikawa Y; Arita M; Akishima-Fukasawa Y; Fujita K; Inomata N; Suzuki T; Namiki A; Mikami T; Ikeda T; Yamazaki J; Ishii T; Akasaka Y
    Cardiovasc Pathol; 2014; 23(2):92-100. PubMed ID: 24322055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of intracoronary versus intravenous FGF-2 in a pig model of chronic myocardial ischemia.
    Sato K; Laham RJ; Pearlman JD; Novicki D; Sellke FW; Simons M; Post MJ
    Ann Thorac Surg; 2000 Dec; 70(6):2113-8. PubMed ID: 11156130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Removal of heparan sulfate by heparinase treatment inhibits FGF-2-dependent smooth muscle cell proliferation in injured rat carotid arteries.
    Kinsella MG; Irvin C; Reidy MA; Wight TN
    Atherosclerosis; 2004 Jul; 175(1):51-7. PubMed ID: 15186946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective pressure-regulated retroinfusion of fibroblast growth factor-2 into the coronary vein enhances regional myocardial blood flow and function in pigs with chronic myocardial ischemia.
    von Degenfeld G; Raake P; Kupatt C; Lebherz C; Hinkel R; Gildehaus FJ; Münzing W; Kranz A; Waltenberger J; Simoes M; Schwaiger M; Thein E; Boekstegers P
    J Am Coll Cardiol; 2003 Sep; 42(6):1120-8. PubMed ID: 13678941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.